Platelet microparticles and calcium homeostasis in acute coronary ischemias

J N Katopodis1, L Kolodny, W Jy

  • 1The William J Harrington Center for Blood Diseases/Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Florida, USA.

Insights

Platelet activation markers, including calcium levels and microparticle shedding, are elevated in acute coronary syndromes. Leukocyte interaction is specifically heightened in unstable angina, indicating distinct pathophysiological roles.

Area of Science:

  • Cardiovascular Research
  • Hematology
  • Clinical Biochemistry

Background:

  • Platelet activation is a key event in acute coronary syndromes (ACS), involving increased cytoplasmic calcium.
  • Markers of platelet activation, such as platelet microparticles (PMP) and CD62p expression, are elevated in ACS.
  • Platelet-leukocyte (P/L) interactions are implicated in the pathophysiology of cardiovascular diseases.

Purpose of the Study:

  • To investigate markers of platelet activation, including free cytoplasmic calcium ([Ca2+]cyt), PMP, CD62p expression, and P/L interaction.
  • To compare these markers in patients with unstable angina (UA), recent myocardial infarction (MI), and control subjects (CTL).
  • To elucidate the role of platelet activation and calcium hemostasis in the pathophysiology of acute coronary ischemia.

Main Methods:

  • Prospective study of 55 patients undergoing coronary angiography for suspected coronary artery disease (CAD).
  • Measurement of [Ca2+]cyt using Fluo-3 and PMP, CD62p expression, and P/L interaction via flow cytometry.
  • Blood samples were collected before heparin infusion from UA, MI, and CTL groups.

Main Results:

  • Platelet microparticle (PMP) levels were significantly higher in both UA and MI groups compared to controls (P < 0.05).
  • Platelet/leukocyte (P/L) interaction was significantly elevated exclusively in the UA group (P < 0.05).
  • Resting [Ca2+]cyt, thrombin-induced Ca2+ influx, and internal calcium release were significantly higher in the combined UA + MI group versus controls (P < 0.001).

Conclusions:

  • Calcium hemostasis and PMP levels differ significantly in patients with acute coronary syndromes, suggesting a role in acute coronary ischemia pathophysiology.
  • Elevated P/L interaction in the UA group points to a specific role for leukocytes in unstable angina.
  • These findings highlight distinct platelet activation profiles in different acute coronary syndromes.
Abstract

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...